Loading clinical trials...
Loading clinical trials...
A Phase 1/2 Trial for Patients With Newly Diagnosed Anal Cancer Treated With Concurrent Radiation Therapy, 5FU, Mitomycin and BMX-001
Conditions
Interventions
BMX-001
Locations
1
United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Start Date
November 28, 2017
Primary Completion Date
July 1, 2026
Completion Date
December 1, 2029
Last Updated
January 26, 2026
NCT03686709
NCT07363187
NCT07128407
NCT06570785
NCT03000751
NCT05804799
Lead Sponsor
University of Nebraska
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions